Clinical Trial Update: A Clinical Study of PD-L1 Antibody ZKAB001（Drug Code） in Locally Advanced and Metastatic Urothelial Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for PD-L1 antibody ZKAB001 in locally advanced and metastatic urothelial carcinoma (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• ZKAB001 (PD-L1 antibody)

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: Urothelial Carcinoma | Phase 1, Phase 2 | Status: UNKNOWN